These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4349812)

  • 21. Low-dose apomorphine attenuates morphine-induced enhancement of brain stimulation reward.
    Knapp CM; Kornetsky C
    Pharmacol Biochem Behav; 1996 Sep; 55(1):87-91. PubMed ID: 8870042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of catecholaminergic drugs on systems of reward and punishment in experiments on cats.
    Patkina NA; Lapin IP
    Pharmacol Biochem Behav; 1976 Sep; 5(3):247-52. PubMed ID: 996056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contributions of dopaminergic and non-dopaminergic neurons to VTA-stimulation induced neurovascular responses in brain reward circuits.
    Brocka M; Helbing C; Vincenz D; Scherf T; Montag D; Goldschmidt J; Angenstein F; Lippert M
    Neuroimage; 2018 Aug; 177():88-97. PubMed ID: 29723641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Narcotic dependence, narcotic action and dopamine receptors.
    Lal H
    Life Sci; 1975 Aug; 17(4):483-95. PubMed ID: 171531
    [No Abstract]   [Full Text] [Related]  

  • 25. Behavioral deficits induced by low doses of apomorphine in rats: evidence for a motivational and cognitive dysfunction which discriminates among neuroleptic drugs.
    Carnoy P; Ravard S; Wemerman B; Soubrie P; Simon P
    Pharmacol Biochem Behav; 1986 Sep; 25(3):503-9. PubMed ID: 2877466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracranial self-stimulation in rats as a function of various stimulus parameters. 3. Influence of apomorphine on medial forebrain bundle stimulation with monopolar electrodes.
    Wauquier A; Niemegeers CJ
    Psychopharmacologia; 1973 May; 30(2):163-72. PubMed ID: 4711373
    [No Abstract]   [Full Text] [Related]  

  • 27. Substantia nigra self-stimulation: dependence on noradrenergic reward pathways.
    Belluzzi JD; Ritter S; Wise CD; Stein L
    Behav Biol; 1975 Jan; 13(1):103-11. PubMed ID: 1111501
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of catecholaminergic substances on the proconvulsive properties of the caudate nucleus].
    Avakian RM; Arushanian EB
    Biull Eksp Biol Med; 1975 Aug; 80(8):66-9. PubMed ID: 171015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of two dopamine receptor blockers on a serotonin-mediated behavioral syndrome in rats.
    Jacobs BL
    Eur J Pharmacol; 1974 Aug; 27(3):363-6. PubMed ID: 4472582
    [No Abstract]   [Full Text] [Related]  

  • 30. Rapid and dissociated changes in sensitivities of different dopamine receptors in mouse brain.
    Costentin J; Protais P; Schwartz JC
    Nature; 1975 Oct; 257(5525):405-7. PubMed ID: 170532
    [No Abstract]   [Full Text] [Related]  

  • 31. Neurochemical mediation of reward: a significant role for dopamine?
    Lippa AS; Antelman SM; Fisher AE; Canfield DR
    Pharmacol Biochem Behav; 1973; 1(1):23-8. PubMed ID: 4590600
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of short- and long-acting dopamine agonists on sensitized dopaminergic neurotransmission in rats with unilateral 6-OHDA lesions.
    Kashihara K; Manabe Y; Murakami T; Abe K
    Life Sci; 2002 Jan; 70(9):1095-100. PubMed ID: 11860157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Main effects of current and pimozide on prepared and learned self-stimulation behaviors are on performance not reward.
    Mekarski JE
    Pharmacol Biochem Behav; 1988 Dec; 31(4):845-53. PubMed ID: 3252276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of the medial preoptic dopaminergic activity on the efficiency of the negative estrogen feedback in prepubertal and cyclic female rats.
    Döcke F; Rohde W; Oelssner W; Schleussner E; Gutenschwager I; Dörner G
    Neuroendocrinology; 1987 Nov; 46(5):445-52. PubMed ID: 3431659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oestrogen modulates dopamine-controlled behaviours in the male ferret.
    Harrer S; Schmidt WJ
    Eur J Pharmacol; 1986 Aug; 128(1-2):129-32. PubMed ID: 3019737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nicotine and brain-stimulation reward: interactions with morphine, amphetamine and pimozide.
    Huston-Lyons D; Sarkar M; Kornetsky C
    Pharmacol Biochem Behav; 1993 Oct; 46(2):453-7. PubMed ID: 8265701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Catecholamines and self-stimulation: reward and performances effects dissociated.
    Franklin KB
    Pharmacol Biochem Behav; 1978 Dec; 9(6):813-20. PubMed ID: 746055
    [No Abstract]   [Full Text] [Related]  

  • 38. Adolescent chronic apomorphine treatment impairs latent inhibition and reduces prefrontal cortex mGluR5 receptor expression in adult rats.
    Shao F; Han X; Li N; Wang W
    Eur J Pharmacol; 2010 Dec; 649(1-3):202-5. PubMed ID: 20868667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of tyrosine hydroxylase but not dopamine-beta-hydroxylase facilitates the action of behaviourally ineffective doses of neuroleptics.
    Antelman SM; Szechtman H; Chin P; Fisher AE
    J Pharm Pharmacol; 1976 Jan; 28(1):66-8. PubMed ID: 6656
    [No Abstract]   [Full Text] [Related]  

  • 40. Neonatal dopamine depletions spare lateral hypothalamic stimulation reward in adult rats.
    Stellar JR; Waraczynski M; Bruno JP
    Pharmacol Biochem Behav; 1988 Jun; 30(2):365-70. PubMed ID: 3174768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.